Quarterly report · Q3
2914.TEDINET S100PFP4
Period2022-01-01 → 2022-09-30
Filed2022-10-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.01T | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥741.7bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.32T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.77T | 2021-01-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥621.5bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥579.3bn | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥196.4bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥480.7bn | 2021-01-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥158.6bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥535.6bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥174.6bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥472.4bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥463.8bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥149.7bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥403.8bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥139.7bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥338.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥338.8bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥113.6bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥403.9bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥138.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥340.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥340.3bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥114.3bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.73T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.63T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.86T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.89T | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.87T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.87T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.60T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.79T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.81T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥778.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥630.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥538.8bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥343.6bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥598.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥428.9bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥70.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥97.5bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥70.1bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥357.4bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥353.1bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥291.3bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥227.53 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥78.74 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥190.76 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥190.95 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥64.03 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥227.45 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥78.71 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥190.68 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥190.87 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥64 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 56.3% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.6% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥8.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-07-01 → 2022-09-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-07-01 → 2022-09-30 | ¥440m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥6.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥643m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | −¥24.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | −¥24.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | −¥22.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | −¥8.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | −¥8.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-07-01 → 2022-09-30 | −¥10.1bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥7.1bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-09-30 | −¥721m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥7.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-09-30 | −¥721m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥48m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-09-30 | −¥1m |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥59.7bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥20.4bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥59.7bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥20.4bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥7.3bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥7.3bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥7.3bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥112.8bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥39.3bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥112.8bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥39.3bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.9bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥722m |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥409m |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥409m |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥306m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥1.83T |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue | 2022-07-01 → 2022-09-30 | ¥681.7bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥1.83T |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue external | 2022-07-01 → 2022-09-30 | ¥681.6bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥215m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥77m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥653.5bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥653.5bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥594.1bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥228.3bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥228.3bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2022-07-01 → 2022-09-30 | ¥203.7bn |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥2.01T |
| —segment total | revenue | 2022-07-01 → 2022-09-30 | ¥741.4bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥2.01T |
| —segment total | revenue external | 2022-07-01 → 2022-09-30 | ¥741.3bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥215m |
| —segment total | revenue intersegment | 2022-07-01 → 2022-09-30 | ¥78m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥662.6bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥662.6bn |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥602.0bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥231.1bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥231.1bn |
| —segment total | segment profit | 2022-07-01 → 2022-09-30 | ¥206.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥5.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-07-01 → 2021-09-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-07-01 → 2021-09-30 | ¥588m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥3.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | −¥28.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | −¥28.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | −¥25.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-07-01 → 2021-09-30 | −¥9.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-07-01 → 2021-09-30 | −¥9.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-07-01 → 2021-09-30 | −¥6.0bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | −¥79m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥25m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥25m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-09-30 | −¥25m |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥56.8bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥19.7bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥56.8bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥19.7bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥6.6bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥6.6bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥6.8bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥106.7bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥36.2bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥106.7bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥36.2bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥0 |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥2.4bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥904m |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥904m |
| jpcrp040300-q3r_E00492-000Processed Foodreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥847m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥1.60T |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue | 2021-07-01 → 2021-09-30 | ¥565.1bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥1.60T |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue external | 2021-07-01 → 2021-09-30 | ¥565.0bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥232m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥82m |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥562.9bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥562.9bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥498.4bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥190.2bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥190.2bn |
| jpcrp040300-q3r_E00492-000Tobaccoreportable segment | segment profit | 2021-07-01 → 2021-09-30 | ¥160.7bn |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥1.76T |
| —segment total | revenue | 2021-07-01 → 2021-09-30 | ¥621.0bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥1.76T |
| —segment total | revenue external | 2021-07-01 → 2021-09-30 | ¥620.9bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥232m |
| —segment total | revenue intersegment | 2021-07-01 → 2021-09-30 | ¥82m |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥571.8bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥571.8bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥506.6bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥194.1bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥194.1bn |
| —segment total | segment profit | 2021-07-01 → 2021-09-30 | ¥164.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,100
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance costs IFRS | CurrentQuarterDuration | 29630000000 | JPY |
| Profit loss before tax IFRS | CurrentQuarterDuration | 174611000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-10-31 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第38期第３四半期（自 2022年７月１日 至 2022年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)日本たばこ産業株式会社 | |
| Company name in english cover page | FilingDateInstant | JAPAN TOBACCO INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 寺畠 正道 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０３（６６３６）２９１４（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員 Corporate Communications 担当 福田 浩之 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門四丁目１番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０３（６６３６）２９１４（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員 Corporate Communications 担当 福田 浩之 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00492 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 29140 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)日本たばこ産業株式会社 | |
| Filer name in english | FilingDateInstant | JAPAN TOBACCO INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q3 | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-01-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2021-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |